JP2005516955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005516955A5 JP2005516955A5 JP2003554683A JP2003554683A JP2005516955A5 JP 2005516955 A5 JP2005516955 A5 JP 2005516955A5 JP 2003554683 A JP2003554683 A JP 2003554683A JP 2003554683 A JP2003554683 A JP 2003554683A JP 2005516955 A5 JP2005516955 A5 JP 2005516955A5
- Authority
- JP
- Japan
- Prior art keywords
- alkoxy
- substituted
- alkyl
- group
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000001424 substituent group Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- -1 cyano, amino Chemical group 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 230000008578 acute process Effects 0.000 claims 3
- 230000006020 chronic inflammation Effects 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 claims 3
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Chemical group 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims 2
- YTLYLLTVENPWFT-UPHRSURJSA-N (Z)-3-aminoacrylic acid Chemical compound N\C=C/C(O)=O YTLYLLTVENPWFT-UPHRSURJSA-N 0.000 claims 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims 1
- 125000006091 1,3-dioxolane group Chemical group 0.000 claims 1
- XOTUAMWIFRDGMZ-UHFFFAOYSA-N 2-chloroprop-2-enoyl chloride Chemical compound ClC(=C)C(Cl)=O XOTUAMWIFRDGMZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- YYFIGOPUHPDIBO-UHFFFAOYSA-N propanoic acid;hydrochloride Chemical compound Cl.CCC(O)=O YYFIGOPUHPDIBO-UHFFFAOYSA-N 0.000 claims 1
- 238000001308 synthesis method Methods 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0130723A GB2387170A (en) | 2001-12-21 | 2001-12-21 | Antiinflammatory pyridinones |
| GBGB0131102.6A GB0131102D0 (en) | 2001-12-21 | 2001-12-31 | Aroyl pyridinones |
| GB0210511A GB0210511D0 (en) | 2002-05-08 | 2002-05-08 | Aroyl pyridinones |
| PCT/EP2002/013930 WO2003053967A1 (en) | 2001-12-21 | 2002-12-09 | Aroyl pyridinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005516955A JP2005516955A (ja) | 2005-06-09 |
| JP2005516955A5 true JP2005516955A5 (https=) | 2006-02-02 |
Family
ID=27256362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554683A Pending JP2005516955A (ja) | 2001-12-21 | 2002-12-09 | アロイル・ピリジノン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050070555A1 (https=) |
| EP (1) | EP1458717B1 (https=) |
| JP (1) | JP2005516955A (https=) |
| AU (1) | AU2002366730A1 (https=) |
| CA (1) | CA2471085A1 (https=) |
| DE (1) | DE60206072T2 (https=) |
| ES (1) | ES2250750T3 (https=) |
| WO (1) | WO2003053967A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1736475A1 (en) * | 2005-06-21 | 2006-12-27 | Ferrer Internacional, S.A. | Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates |
| JP2007217322A (ja) * | 2006-02-15 | 2007-08-30 | Ube Ind Ltd | 慢性閉塞性肺疾患の治療又は予防のための医薬組成物 |
| BRPI1006150A2 (pt) | 2009-01-13 | 2018-01-16 | Interquim Sa | Processo para preparação de n-[5-(3-dimetilamino- acriloil)-2fluorofenil]-n-metil-acetamida |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358891A1 (fr) * | 1976-07-22 | 1978-02-17 | Yamanouchi Pharma Co Ltd | Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires |
| EP0948496A2 (en) * | 1996-12-05 | 1999-10-13 | Amgen inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
-
2002
- 2002-12-09 EP EP02805310A patent/EP1458717B1/en not_active Expired - Lifetime
- 2002-12-09 WO PCT/EP2002/013930 patent/WO2003053967A1/en not_active Ceased
- 2002-12-09 JP JP2003554683A patent/JP2005516955A/ja active Pending
- 2002-12-09 CA CA002471085A patent/CA2471085A1/en not_active Abandoned
- 2002-12-09 US US10/498,870 patent/US20050070555A1/en not_active Abandoned
- 2002-12-09 DE DE60206072T patent/DE60206072T2/de not_active Expired - Fee Related
- 2002-12-09 ES ES02805310T patent/ES2250750T3/es not_active Expired - Lifetime
- 2002-12-09 AU AU2002366730A patent/AU2002366730A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1133627C (zh) | N-苄基二氧代噻唑烷基苯甲酰胺衍生物的制造中间体及其制造方法 | |
| CN1105708C (zh) | 1-苯基吡唑化合物类及其药学应用 | |
| JP2009519226A5 (https=) | ||
| JP2008511601A5 (https=) | ||
| JP2004518723A5 (https=) | ||
| TNSN07361A1 (en) | 3,4-substituted pyrrolidine derivatives for the treatment of hypertension | |
| JP2007508360A5 (https=) | ||
| RU2005128190A (ru) | Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации | |
| CA2514384A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| JP2009519903A5 (https=) | ||
| JP2006507220A5 (https=) | ||
| RU2011133128A (ru) | Противоопухолевые соединения дигидропиран-2-она | |
| JP2005536503A5 (https=) | ||
| CN1127114A (zh) | 取代的4-苯基-6-氨基烟酸衍生物作为药物的应用 | |
| JP2007518767A5 (https=) | ||
| JPH05140063A (ja) | ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤 | |
| JP2007538031A5 (https=) | ||
| JP2021522327A5 (https=) | ||
| JP2005517008A5 (https=) | ||
| JP5315336B2 (ja) | 精神疾患治療用の新規化合物とその調剤及び使用 | |
| JP2004517088A5 (https=) | ||
| JP2005516955A5 (https=) | ||
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| CN1098848C (zh) | 香叶木甙元的新的酸和酯及含它们的药物组合物 | |
| JP2009519227A5 (https=) |